Latest Board Appointment News

ION Video has appointed former Apple executive Kelli Richards as its inaugural Advisory Board member, aiming to leverage her Silicon Valley connections and media tech expertise to accelerate commercialisation.

Challenger Gold's Pre-Feasibility Study for the Hualilan Project delivers a robust US$1.45 billion pre-tax NPV, 1.84 million ounces gold equivalent production, and a low upfront capital strategy.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Altech Batteries has decided to discontinue its Silumina AnodesTM project after six years, shifting full focus to its CERENERGY® solid-state battery technology amid ongoing joint venture talks.

WA Kaolin is seeking up to A$34.9 million through a fully underwritten entitlement offer aimed at restructuring its balance sheet, reducing shareholder loans, and funding operational improvements at its Wickepin kaolin project.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.

Odessa Minerals has raised $2.65 million through a strongly supported placement and appointed Sam Brooks, an experienced geologist, to its board to boost project acquisition efforts.

MC Mining has secured a US$90 million capital injection from Kinetic Development Group, which now holds a 51% controlling stake, accelerating the Makhado Project towards production. New board appointments signal a strategic shift as the company pivots from development to operational ramp-up.

Cann Group’s CEO Jenni Pilcher steps down after leading a dramatic debt reduction and cost overhaul. Chairman Mike Ryan takes interim charge as the company hunts for a new CEO.

White Cliff Minerals has recommenced drilling at its Rae Copper Project, delivering high-grade copper-silver results and metallurgical testwork supporting simplified processing. The company agreed to sell its Great Bear Project for A$5.8 million, refocusing resources on Rae.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.